Documents | Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma | Guidance | NICE

Documents

A list of downloadable documents created during development.

Lymphoma (non Hodgkin's, relapsed, refractory) - pixantrone monotherapy: Equality Impact Assessment - guidance development

Lymphoma (non Hodgkin's, relapsed, refractory) - pixantrone monotherapy: Equality Impact Assessment - guidance development ^{PDF 85.52 KB} 26 February 2014

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 document ^{PDF 417.01 KB} 31 December 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report 2 information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report 2 ^{PDF 2.26 MB} 31 December 2013

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation 2

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation 2
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation document information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report ^{PDF 4.08 MB} 15 October 2013

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation document information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: pre-meeting briefing ^{PDF 552.09 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Evidence Review Group report ^{PDF 2.91 MB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Evidence Review group report - factual accuracy check ^{PDF 64.99 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: erratum to the ERG report ^{PDF 138.06 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Cell Therapeutics ^{PDF 1.74 MB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: clarification
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: NICE clarification letter ^{PDF 113.23 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Cell Therapeutics response to the NICE clarification letter ^{PDF 330.85 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appendix to manufacturer's clarification response ^{PDF 1022.15 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: patient group, professional group and NHS organisation submission statements
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Lymphoma Association ^{PDF 44.27 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: The Royal College of Physicians ^{PDF 45.15 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: expert written personal statements
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: McMillan ^{PDF 27.35 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Pettengell ^{PDF 27.47 KB} 11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Wilson ^{PDF 26.46 KB} 11 April 2013

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE's response to consultees and commentator comments on the draft scope and provisional matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE's response to consultees and commentator comments on the draft scope and provisional matrix ^{PDF 132.05 KB} 04 October 2012

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope ^{PDF 50.39 KB} 04 October 2012

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix ^{PDF 54.94 KB} 04 October 2012

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix (superseded) ^{PDF 33.33 KB} 28 December 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope (superseded) ^{PDF 30.49 KB} 28 December 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE response to comments on draft scope (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE response to comments on draft scope (superseded) ^{PDF 96.84 KB} 28 December 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): draft scope

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): draft scope ^{PDF 33.48 KB} 21 January 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): provisional matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): provisional matrix ^{PDF 32.21 KB} 21 January 2011